A detailed history of Verition Fund Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 37,358 shares of VNDA stock, worth $170,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,358
Holding current value
$170,352
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.91 - $6.5 $146,069 - $242,827
37,358 New
37,358 $211,000
Q4 2023

Feb 14, 2024

SELL
$3.38 - $4.58 $498,212 - $675,092
-147,400 Reduced 63.02%
86,500 $365,000
Q3 2023

Nov 14, 2023

BUY
$4.28 - $6.57 $1 Million - $1.54 Million
233,900 New
233,900 $1.01 Million
Q2 2021

Aug 16, 2021

SELL
$15.71 - $21.51 $180,555 - $247,214
-11,493 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$13.42 - $20.28 $154,236 - $233,078
11,493 New
11,493 $172,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $258M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.